Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection

Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study aimed to evaluate the efficacy of adjuvant CIK application in solitary HCC patients undergoing curative resect...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Medicine (Baltimore)
Κύριοι συγγραφείς: Chen, Jian-Lin, Lao, Xiang-Ming, Lin, Xiao-Jun, Xu, Li, Cui, Bo-Kang, Wang, Jun, Lin, Guo-He, Shuang, Ze-Yu, Mao, Yi-Ze, Huang, Xin, Yun, Jing-Ping, Jin, Jie-Tian, Li, Sheng-Ping
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Wolters Kluwer Health 2016
Θέματα:
7300
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748913/
https://ncbi.nlm.nih.gov/pubmed/26844496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002665
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια